World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 16 December 2017
Main ID:  NCT02534688
Date of registration: 19/08/2015
Prospective Registration: No
Primary sponsor: King Chulalongkorn Memorial Hospital
Public title: Effectiveness of Levonorgestrel-intrauterine System (LNG-IUS) Versus Depot Medroxyprogesterone Acetate (DMPA) in Treatment of Pelvic Pain in Clinically Diagnosed Endometriotic Patients
Scientific title: Effectiveness of Levonorgestrel-intrauterine System (LNG-IUS) Versus Depot Medroxyprogesterone Acetate (DMPA) in Treatment of Pelvic Pain in Clinically Diagnosed Endometriotic Patients
Date of first enrolment: June 2015
Target sample size: 50
Recruitment status: Completed
URL:  https://clinicaltrials.gov/show/NCT02534688
Study type:  Interventional
Study design:  Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).  
Phase:  Phase 4
Countries of recruitment
Thailand
Contacts
Key inclusion & exclusion criteria

Inclusion Criteria:

- Female age 18-45 yr

- Moderate to severe pelvic pain categorized by VAS >50

- Previous sexual intercourse

Exclusion Criteria:

- Co-existing other genital tract disease associated pain

- Previous hormonal use within 3 months

- History of DMPA treatment failure

- WHO eligibility criteria 2009 for DMPA and LNG-IUS Category 3,4

- Fertility desire in upcoming 1 year



Age minimum: 18 Years
Age maximum: 45 Years
Gender: Female
Health Condition(s) or Problem(s) studied
Endometriosis
Intervention(s)
Drug: LNG-IUS
Drug: DMPA
Primary Outcome(s)
Severity of pelvic pain : measured by visual analog scale [Time Frame: 6 months]
Secondary Outcome(s)
Lipid profile : total cholesterol, triglyceride, LDL, HDL [Time Frame: 6months]
Quality of life measured by Quesionaire SF 36 Thai version [Time Frame: 6 months]
Secondary ID(s)
Kingchulalongkorn
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history